Predicting Fatal Drug Poisoning Among People Living with HIV‑HCV Co‑Infection
Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025
A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis
Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D., Psychiatry Res. 2025
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Uyen Do, Sarah Larney, Matthew Bonn, Ingrid Matei, Camille Zolopa, Amy Bergeron, Mohammad Karamouzian, Elaine Hyshka, Thomas D. Brothers, Nikki Bozinoff, Dan Werb, Didier Jutras‑Aswad, Stine Høj, Isabelle Boisvert, Igor Yakovenko, Julie Bruneau, International Journal of Drug Policy, 2025
Harnessing telemedicine to deliver patient‑centered opioid agonist treatment within a community‑based harm reduction service: a mixed methods evaluation
Stine Bordier Høj, Rémi Coignard‑Friedman, Aissata Sako, Catherine de Montigny, Marie‑Ève Beauchemin‑Nadeau, Robert Léandre, Nanor Minoyan, Geneviève Boyer‑Legault, Sofiane Chougar, Sara‑Kim Lamont, Julie Bruneau, Harm Reduction Journal , 2025
The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study
Lim J, Bruneau J, Platt RW, Panagiotoglou D., Drug Saf. 2025
Impacts of the COVID-19 Pandemic on Opioid Use Disorder and Services for American Indian and Alaska Native Communities
Parker DG, Radin S, Sorlagas N, Wendt DC., Health Res. 2025
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC., Psychol Addict Behav. 2025
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
Kira London‑Nadeau, Christian Barborini, Rebecca Haines‑Saah, Misha Bazarov, Sean Bristowe, Misha Khorkhordina, Mélodie Lemay‑Gaulin, Catherine Gorka, Robert‑Paul Juster, Heath D’Alessio, Nicholas Chadi, International Journal of Drug Policy, 2025
Exploring Pain‑Severity and Psychological‑Flexibility Trajectories During Group‑Based Psychotherapy for Chronic Pain
Élisabeth Lamoureux, Karen Ghoussoub, Yoram Shir, Marc O. Martel, Zakhar Prylutskyy, M. Gabrielle Pagé, International Journal of Group Psychotherapy, 2025
